No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2990 |
4. Check minimum number of eventsNone |
2990 |
5. Include endpointsNone |
2990 |
6. Filter based on genotype QC (FinnGen only) |
2990 |
Control definitions (FinnGen only)
- Control exclude
- J10_LOWERINF
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J20-J22
- Name in latin
- Bronchiolitis acuta
Similar endpoints
↥List of similar endpoints to
Acute bronchiolitis
based on the number of shared cases.
Similar with more cases:
- Other acute lower respiratory infections
- Bronchitis
- Asthma/COPD-related acute respiratory infections
- COPD/asthma/ILD related infections
- COPD/asthma related infections
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 125428 | 48749 | 76593 |
| Only index persons | 76962 | 29799 | 47163 |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.85 | 1.40 | 2.14 |
| Only index persons | 1.53 | 1.10 | 1.80 |
| Median age at first event (years) | |||
| Whole population | 1.09 | 1.04 | 1.04 |
| Only index persons | 1.08 | 1.11 | 1.07 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2990 | 1588 | 1402 |
| Unadjusted period prevalence (%) | 0.58 | 0.54 | 0.62 |
| Median age at first event (years) | 1.55 | 1.58 | 1.52 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2165
- Matched controls
- 20593
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
+∞
323.0
475
*
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
+∞
323.0
1421
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
6.8
276.0
837
1734
4661A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchiolitis
+∞
238.8
229
*
R03BA05
ATC
fluticasone; inhalant
5.1
209.8
822
2191
J45.1
ICD-10 Finland
Nonallergic asthma
8.7
208.4
497
683
R03AC02
ATC
salbutamol; inhalant
4.0
194.0
1455
7007
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.3
183.8
563
1095
J45.9
ICD-10 Finland
Asthma, unspecified
5.2
181.0
669
1626
R03BA02
ATC
budesonide; inhalant
4.5
149.4
628
1698
J21.99
ICD-10 Finland
Acute bronchiolitis, unspecified
290.0
111.9
115
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.6
107.9
426
1043
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.5
99.8
401
993
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.5
98.5
546
1794
R03AC03
ATC
terbutaline; inhalant
4.2
98.2
428
1145
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.1
86.9
599
2281
R03CC02
ATC
salbutamol; systemic
2.7
86.1
811
3759
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
157.8
75.0
80
5
R03DC03
ATC
montelukast; oral
3.1
67.3
442
1593
H66.9
ICD-10 Finland
Otitis media, unspecified
2.8
61.7
467
1837
H02AB06
ATC
prednisolone; systemic
2.2
57.6
777
4131
J46
ICD-10 Finland
Status asthmaticus
10.9
51.6
102
93
J45.8
ICD-10 Finland
Mixed asthma
6.9
51.3
134
195
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.1
49.0
205
510
R96
ICPC
Asthma
3.4
46.8
249
758
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
6.1
45.2
129
211
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
44.0
1315
9243
J45
ICD-10 Finland
Asthma
3.2
44.0
254
820
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
41.9
1292
9107
XG410
NOMESCO Finland
Flow-volume spirometry
4.5
41.6
155
344
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.6
40.5
198
562
R06.2
ICD-10 Finland
Wheezing
3.8
38.3
172
454
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
35.9
594
3302
R03DA04
ATC
theophylline; systemic, rectal
5.4
35.4
111
204
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
5.6
35.2
106
186
R50.9
ICD-10 Finland
Fever, unspecified
2.2
32.0
392
1912
J01FA10
ATC
azithromycin; systemic
1.8
32.0
1548
12046
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.1
31.3
128
311
R03AK07
ATC
formoterol and budesonide; inhalant
2.4
31.2
304
1332
R03BB04
ATC
tiotropium bromide; inhalant
4.1
30.5
124
300
R06.0
ICD-10 Finland
Dyspnoea
2.1
30.1
381
1884
R03BA01
ATC
beclometasone; inhalant
2.7
29.5
212
785
R06AE07
ATC
cetirizine; oral
1.7
28.2
948
6525
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
28.0
154
477
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
28.0
619
3750
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
27.7
892
6053
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
+∞
27.6
27
*
EMB30
NOMESCO Finland
Adenotomy
2.0
27.6
412
2169
Z3231
NOMESCO Finland
Registered nurse
1.8
25.0
569
3458
C03CA01
ATC
furosemide; systemic
2.2
24.9
274
1263
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
24.6
168
601
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
24.3
209
854
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.1
23.9
301
1471
L20.0
ICD-10 Finland
Besnier prurigo
2.0
23.5
339
1752
J04.0
ICD-10 Finland
Acute laryngitis
2.6
23.2
184
719
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
23.0
361
1925
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.3
22.7
55
73
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.5
22.6
82
178
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.3
22.6
71
132
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.6
22.6
105
286
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
+∞
22.5
22
*
ZXE00
NOMESCO Finland
One hour or less
1.6
22.4
696
4604
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
22.3
232
1041
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
2.0
21.9
308
1571
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.2
21.9
243
1124
R05
ICD-10 Finland
Cough
1.9
21.7
388
2164
J01MA14
ATC
moxifloxacin; systemic
3.5
21.5
105
298
J01CA04
ATC
amoxicillin; systemic
1.9
21.3
1946
16896
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
20.9
515
3178
J01MA12
ATC
levofloxacin; systemic
2.3
20.3
194
834
R03AC12
ATC
salmeterol; inhalant
4.2
20.1
79
186
XW000
NOMESCO Finland
Bone marrow biopsy
4.1
20.1
80
191
L27.2
ICD-10 Finland
Dermatitis due to ingested food
2.8
19.8
133
472
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.5
19.6
59
105
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
19.3
91
252
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
19.1
340
1884
H02AB07
ATC
prednisone; oral
2.4
19.1
167
687
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.2
19.0
101
307
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.6
18.6
65
137
Z3226
NOMESCO Finland
Physiotherapist
1.8
18.5
330
1833
J01DB01
ATC
cefalexin; oral
1.5
18.2
1578
13054
XQ800
NOMESCO Finland
Prick test
2.1
18.2
223
1075
R4110
NOMESCO Finland
Physiotherapy
1.8
18.0
376
2197
J35.2
ICD-10 Finland
Hypertrophy of adenoids
1.9
17.8
273
1435
127
Kela drug reimbursment
Transplant complication
5.3
17.7
54
98
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
17.7
285
1527
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
17.5
261
1359
ZXA10
NOMESCO Finland
Bilateral
1.8
17.4
307
1694
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
17.2
415
2527
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
17.2
441
2732
ZXD05
NOMESCO Finland
Urgent procedure
1.6
16.9
476
3023
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.5
16.9
80
223
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
16.9
451
2826
UDC00
NOMESCO Finland
Ear microscopy
2.1
16.5
192
903
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
16.5
105
360
ZX108
NOMESCO Finland
Inhalation
11.1
16.4
31
27
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
5.0
16.4
53
103
A41.9
ICD-10 Finland
Sepsis, unspecified
3.6
16.4
76
208
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.7
16.2
41
59
R03AK08
ATC
formoterol and beclometasone; inhalant
4.2
16.2
62
144
I50.9
ICD-10 Finland
Heart failure, unspecified
2.5
16.1
128
501
D07AA02
ATC
hydrocortisone; topical
1.7
16.0
408
2521
E000001
ATC
NA
1.6
15.7
504
3303
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
4.6
15.4
54
115
J20
ICD-10 Finland
Acute bronchitis
2.3
15.2
143
611
R01AD09
ATC
mometasone; nasal
1.5
15.2
743
5357
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
6.8
15.2
38
54
A07AA02
ATC
nystatin; oral
3.2
15.1
82
254
J01FA09
ATC
clarithromycin; systemic
1.5
14.9
590
4055
C01CA24
ATC
epinephrine; parenteral
2.1
14.9
176
835
R02
ICPC
Shortness of breath/dyspnoea
1.9
14.9
226
1184
R03BB01
ATC
ipratropium bromide; inhalant
4.3
14.8
55
124
J01FA06
ATC
roxithromycin; oral
1.6
14.8
403
2528
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
14.8
314
1837
501
Kela drug reimbursment
Cow's milk and / or soy protein allergy in young children
2.4
14.8
129
532
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
14.7
213
1093
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.6
14.7
67
182
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.9
14.5
90
305
TGC00
NOMESCO Finland
Bronchial lavation
6.3
14.4
38
58
J01FF01
ATC
clindamycin; systemic
1.7
14.4
337
2024
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.2
14.4
55
128
J01DA01
ATC
[U] cefalexin; systemic
1.4
14.4
962
7368
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
14.3
212
1097
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
14.3
182
888
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
14.3
282
1611
ZX120
NOMESCO Finland
Intravenous
2.3
14.2
140
611
A08.0
ICD-10 Finland
Rotaviral enteritis
3.5
14.0
65
179
Z2221
NOMESCO Finland
Medical doctor
1.6
14.0
440
2859
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.4
13.8
41
73
WX892
NOMESCO Finland
Monitored bed care
2.4
13.8
114
458
H02AB04
ATC
methylprednisolone; systemic
2.1
13.7
157
735
UGC02
NOMESCO Finland
Rigid bronchoscopy
7.9
13.7
31
38
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.9
13.7
83
276
L04AA06
ATC
mycophenolic acid; systemic
4.7
13.6
46
95
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
13.6
408
2622
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
13.5
159
750
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
13.4
694
5032
N02AA05
ATC
oxycodone; systemic
2.3
13.3
132
577
E0000UV
ATC
NA
1.4
13.3
833
6271
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.5
13.2
61
168
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
13.2
80
266
H02AB09
ATC
hydrocortisone; systemic
3.0
13.2
75
240
I50.0
ICD-10 Finland
Congestive heart failure
2.9
13.1
78
258
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.6
13.0
99
379
R06AX27
ATC
desloratadine; oral
1.5
12.7
603
4285
P07.3
ICD-10 Finland
Other preterm infants
2.9
12.7
78
263
A02BC01
ATC
omeprazole; systemic
1.7
12.7
313
1908
R01AD08
ATC
fluticasone; nasal
1.6
12.5
394
2554
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
12.4
153
737
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.4
12.4
104
419
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
12.3
115
491
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.8
12.2
204
1101
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
12.1
100
400
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
5.7
12.1
34
57
R03BC01
ATC
cromoglicic acid; inhalant
4.9
12.1
39
77
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.0
12.1
48
117
A06AD11
ATC
lactulose; oral
1.9
12.0
180
937
C03DA01
ATC
spironolactone; oral
2.3
11.9
107
446
R11
ICD-10 Finland
Nausea and vomiting
1.9
11.9
189
1004
Z2445
NOMESCO Finland
Psychologist
1.9
11.8
186
984
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.3
11.7
57
165
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
11.7
76
265
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
11.6
126
577
R06AE09
ATC
levocetirizine; oral
1.6
11.4
312
1951
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
11.4
236
1366
A01AB09
ATC
miconazole; local oral
2.0
11.3
155
779
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.6
11.3
308
1924
J21.8
ICD-10 Finland
Acute bronchiolitis due to other specified organisms
+∞
11.2
11
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
2.7
11.2
75
268
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
11.2
274
1664
L03AA02
ATC
filgrastim; parenteral
4.1
11.2
43
102
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
11.2
136
655
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.6
11.1
50
136
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.4
11.1
91
365
ZXD20
NOMESCO Finland
Day surgery
1.8
11.0
194
1068
A03FA02
ATC
cisapride; oral, rectal
2.1
10.9
116
529
R03CC03
ATC
terbutaline; systemic
1.9
10.8
152
773
Z2446
NOMESCO Finland
Social worker
1.8
10.8
194
1072
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
10.8
103
445
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
10.8
250
1493
A11CC03
ATC
alfacalcidol; systemic
4.0
10.8
42
101
602
Kela drug reimbursment
Children's severe malnutrition
3.6
10.8
47
125
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.2
10.7
55
166
153
Kela drug reimbursment
Lenalidomid
41.4
10.7
13
*
B03XA01
ATC
erythropoietin; parenteral
7.7
10.7
24
30
B34.9
ICD-10 Finland
Viral infection, unspecified
2.1
10.6
123
580
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.3
10.6
53
157
WX722
NOMESCO Finland
PEEP
3.6
10.6
46
122
N05CF01
ATC
zopiclone; oral
1.6
10.5
263
1605
WW300
NOMESCO Finland
Transfer of autologic stem cells
14.8
10.5
17
11
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
11.4
10.5
19
16
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
10.4
50
144
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
10.3
181
994
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
3.9
10.3
41
101
R03AC13
ATC
formoterol; inhalant
3.2
10.3
53
161
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.0
10.3
133
656
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
10.3
102
451
4659X
ICD-9 Finland
Acute upper respiratory infections of multiple or unspecified sites, Unspecified site
4.4
10.2
36
79
J30.3
ICD-10 Finland
Other allergic rhinitis
2.3
10.2
96
412
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
10.2
135
673
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
10.2
154
806
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
8.1
10.1
22
26
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
10.1
114
532
N03AX16
ATC
pregabalin; oral
1.7
10.0
199
1137
E000002
ATC
NA
1.5
10.0
320
2075
H65.2
ICD-10 Finland
Chronic serous otitis media
3.1
10.0
54
170
R06AX13
ATC
loratadine; oral
1.6
9.9
279
1753
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
2.5
9.9
74
284
R51.80
ICD-10 Finland
Headache
1.5
9.9
337
2220
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
2.1
9.8
108
500
L04AX04
ATC
lenalidomide; oral
38.2
9.7
12
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
13.9
9.7
16
11
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
9.6
136
694
N02AX02
ATC
tramadol; systemic, rectal
1.5
9.5
371
2512
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.1
9.5
29
55
B01AA03
ATC
warfarin; systemic
1.9
9.3
145
767
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.3
9.2
44
127
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.4
9.2
43
122
J96.1
ICD-10 Finland
Chronic respiratory failure
6.1
9.1
24
38
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.5
9.1
68
260
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
11.8
9.1
16
13
A02BC02
ATC
pantoprazole; systemic
1.4
9.1
664
5050
R01AD12
ATC
fluticasone furoate; nasal
1.4
9.1
546
4021
WW500
NOMESCO Finland
Blood transfusion
2.8
9.0
55
188
WX882
NOMESCO Finland
High dependency care
2.4
9.0
75
305
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
9.0
235
1447
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.0
9.0
107
513
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
9.0
45
135
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.7
9.0
37
95
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.2
8.9
85
370
UJD02
NOMESCO Finland
Gastroscopy
2.7
8.8
58
208
E000003
ATC
NA
2.1
8.8
101
476
3810A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media
4.8
8.8
28
56
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
8.8
299
1965
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.2
8.7
44
133
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
4.0
8.7
33
79
J01MA02
ATC
ciprofloxacin; systemic
1.5
8.6
376
2601
F80.1
ICD-10 Finland
Expressive language disorder
2.7
8.6
56
199
J01AA02
ATC
doxycycline; systemic
1.3
8.6
801
6310
TAB00
NOMESCO Finland
Lumbar puncture
2.3
8.6
75
313
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
8.6
327
2205
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
8.5
160
900
TK800
NOMESCO Finland
Hemodialysis
4.1
8.4
31
72
A12AA04
ATC
calcium carbonate; oral
4.6
8.4
28
59
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
6.0
8.4
22
35
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
8.3
273
1778
C90.0
ICD-10 Finland
Multiple myeloma
8.6
8.2
17
19
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
8.2
56
205
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.7
8.1
52
183
6BA02
NOMESCO Finland
NA
7.0
8.1
19
26
F83
ICD-10 Finland
Mixed specific developmental disorders
2.5
8.1
59
224
R04.2
ICD-10 Finland
Haemoptysis
3.8
8.1
32
80
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
8.1
108
542
E000006
ATC
NA
1.8
8.0
125
660
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
8.1
8.0
17
20
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
13.8
8.0
13
9
J01DA08
ATC
[U] cefaclor; oral
1.4
7.9
432
3114
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
7.9
78
344
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.3
7.9
38
111
C07AB07
ATC
bisoprolol; oral
1.4
7.9
343
2367
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
7.9
90
425
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
7.9
427
3077
XQ830
NOMESCO Finland
Exposure to foodstuff
6.2
7.8
20
31
FM2CE
NOMESCO Finland
NA
2.5
7.8
57
217
C07AB02
ATC
metoprolol; systemic
1.7
7.8
163
949
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
3.1
7.7
40
124
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
7.7
140
782
R03BA08
ATC
ciclesonide; inhalant
2.0
7.7
92
442
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
7.6
90
430
H65.0
ICD-10 Finland
Acute serous otitis media
2.4
7.6
60
239
RD210
NOMESCO Finland
NA
2.2
7.6
73
318
R53
ICD-10 Finland
Malaise and fatigue
1.4
7.6
323
2224
TJD20
NOMESCO Finland
Change of gastrostomy tube
7.4
7.6
17
22
WW409
NOMESCO Finland
Other aferesis
9.0
7.5
15
16
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.5
210
1316
M04AA01
ATC
allopurinol; systemic
2.0
7.5
93
453
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
7.4
116
615
J96.0
ICD-10 Finland
Acute respiratory failure
6.1
7.4
19
30
Z94.0
ICD-10 Finland
Kidney transplant status
4.0
7.4
28
68
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
7.3
98
491
C01DA14
ATC
isosorbide mononitrate; oral
1.8
7.3
112
592
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
7.3
314
2164
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
7.2
183
1118
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
3.0
7.2
38
120
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
5.5
7.2
20
35
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
6.8
7.2
17
24
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
7.2
7
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.9
7.1
106
553
J01FA01
ATC
erythromycin; systemic
1.5
7.1
216
1381
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
7.1
126
696
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.5
7.1
31
85
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.6
7.1
50
188
XA800
NOMESCO Finland
Neuropsychological investigation
2.0
7.1
84
404
R74
ICPC
Upper respiratory infection acute
1.3
7.1
796
6395
R05
ICPC
Cough
1.4
7.0
453
3355
ZX112
NOMESCO Finland
Subcutaneous
3.1
7.0
36
112
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
7.0
127
709
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
7.0
268
1807
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
7.0
35
107
Z94.2
ICD-10 Finland
Lung transplant status
19.1
6.9
10
5
I25.2
ICD-10 Finland
Old myocardial infarction
2.4
6.9
53
209
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.8
6.9
123
682
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
6.9
58
239
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
4.0
6.9
26
63
R03BA07
ATC
mometasone; inhalant
4.3
6.9
24
54
SPAT1255
SPAT
Intravenous administration of medicine
2.3
6.9
63
270
UJF32
NOMESCO Finland
Coloscopy
1.5
6.9
215
1388
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.0
6.8
88
435
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
6.8
146
856
WW200
NOMESCO Finland
Immunization
2.5
6.8
51
197
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
6.3
6.8
17
26
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
8.4
6.8
14
16
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
8.4
6.8
14
16
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.0
6.8
81
389
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
4.8
6.8
21
42
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.6
6.7
45
165
137
Kela drug reimbursment
Uraemia requiring dialysis
5.4
6.7
19
34
N02BE01
ATC
paracetamol; systemic, rectal
1.3
6.7
1274
10903
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.6
6.7
47
175
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
6.7
197
1251
B02.9
ICD-10 Finland
Zoster without complication
2.3
6.7
59
248
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
6.7
919
7559
J35.1
ICD-10 Finland
Hypertrophy of tonsils
1.8
6.6
106
567
SPAT1262
SPAT
Handing over of treatment supplies
1.6
6.6
157
947
R62.0
ICD-10 Finland
Delayed milestone
2.4
6.6
53
213
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
10.4
6.6
12
11
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
6.6
94
485
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.6
6.6
27
71
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
6.5
138
805
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
6.5
130
748
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
6.5
63
276
N03AX12
ATC
gabapentin; oral
1.7
6.5
121
680
C01AA05
ATC
digoxin; systemic
2.0
6.5
77
371
L04AA01
ATC
[U] ciclosporin; systemic
4.2
6.5
23
53
B01AC04
ATC
clopidogrel; oral
1.9
6.4
91
467
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.2
6.4
60
259
J05AH02
ATC
oseltamivir; oral
4.3
6.4
22
49
JN4BD
NOMESCO Finland
Extensive body CT
1.9
6.4
85
429
I50.1
ICD-10 Finland
Left ventricular failure
2.7
6.4
41
145
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
11.7
6.4
11
9
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.6
6.3
17
29
A04AA01
ATC
ondansetron; systemic, rectal
1.9
6.3
86
436
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
6.3
207
1349
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
5.2
6.3
18
33
D07AB08
ATC
desonide; topical
1.5
6.3
185
1174
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.0
6.3
33
105
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.6
6.3
26
69
N05AA01
ATC
chlorpromazine; systemic, rectal
6.5
6.3
15
22
RS220
NOMESCO Finland
NA
3.1
6.3
32
100
M01AE02
ATC
naproxen; oral, rectal
1.3
6.2
1166
9923
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
6.2
45
173
280
Kela drug reimbursment
Clopidogrel
5.9
6.2
16
26
X58
ICD-10 Finland
Exposure to other specified factors
1.4
6.2
258
1768
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.1
6.2
18
34
4451
FHL
Guitar cutting
2.0
6.2
77
380
C08CA01
ATC
amlodipine; oral
1.5
6.2
201
1309
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
6.2
147
887
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.6
6.1
41
151
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
6.1
116
657
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
7.8
6.1
13
16
XG466
NOMESCO Finland
Sleep oxymetry
3.6
6.1
25
66
JDB00
NOMESCO Finland
Gastrostomy
10.5
6.1
11
10
RK290
NOMESCO Finland
NA
10.5
6.1
11
10
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.5
6.1
26
71
UKC02
NOMESCO Finland
Cystoscopy
1.7
6.1
127
739
3720A
ICD-9 Finland
Disorders of conjunctiva, Acute conjunctivitis
25.4
6.1
8
*
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
2.2
6.1
58
256
ZXA05
NOMESCO Finland
Left side
1.5
6.1
232
1563
R95
ICPC
Chron obstructive pulmonary disease
4.7
6.0
19
39
RS221
NOMESCO Finland
NA
2.8
6.0
35
118
R81
ICPC
Pneumonia
2.5
6.0
43
164
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
6.0
71
341
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
495
2223
2.22
49.89
2.7
1.8
—
—
—
0
0
(3009343) pH of Capillary blood
443
1943
2.25
47.09
11.5
7.1
ph
7.4
7.4
0.57
31
108
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
443
1949
2.24
46.72
11.5
7.1
kpa
5.1
5.1
0.08
427
1862
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
437
1918
2.24
46.32
11.5
7.1
mmol/l
1.1
1.0
0.16
309
1376
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
362
1487
2.37
44.71
2.4
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
363
1508
2.34
43.65
2.5
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1091
6713
1.76
42.26
8.4
7.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
361
1559
2.24
39.42
12.3
7.6
kpa
9.4
9.7
2.07
348
1493
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
148
405
3.41
38.99
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
148
406
3.40
38.84
1.7
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
621
3301
1.89
38.37
5.3
3.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
365
1605
2.20
38.07
12.0
7.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1333
8883
1.67
36.94
9.0
7.2
%
0.6
0.6
0.16
1266
8360
(3002032) Base excess in Venous blood by calculation
462
2268
2.00
35.88
8.7
7.9
mmol/l
1.6
1.3
1.13
383
1792
(3013115) Eosinophils [#/volume] in Blood
1453
9953
1.65
35.71
9.3
7.5
e9/l
0.2
0.2
5.72
1272
8656
(3006315) Basophils [#/volume] in Blood
1411
9623
1.64
35.02
8.9
7.0
e9/l
0.0
0.0
0.42
1209
8214
(3000991) Gas panel - Venous blood
425
2048
2.02
34.69
11.2
9.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
460
2284
1.97
34.48
8.7
7.9
kpa
6.0
5.8
2.26
453
2218
(3001604) Monocytes [#/volume] in Blood
1405
9596
1.64
34.46
8.9
7.0
e9/l
0.6
0.6
4.18
1206
8190
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
141
406
3.24
34.25
2.5
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
818
4862
1.72
34.21
8.7
7.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1364
9281
1.63
33.68
9.1
7.2
%
8.3
8.2
0.54
1301
8751
(3019198) Lymphocytes [#/volume] in Blood
1459
10104
1.62
33.44
8.7
6.9
e9/l
2.2
2.1
1.03
1290
8842
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
354
1615
2.11
33.41
12.0
7.3
mmol/l
24.1
24.2
0.28
348
1597
(3006504) Eosinophils/100 leukocytes in Blood
1355
9220
1.62
33.32
9.0
7.0
%
3.2
2.9
4.41
1287
8666
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
114
293
3.60
33.01
2.6
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
107
271
3.65
31.66
2.1
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1395
9637
1.60
31.60
8.5
6.8
%
52.3
52.8
0.60
1331
9108
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
136
403
3.14
31.50
2.6
1.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
383
1839
2.01
31.38
8.2
8.2
mmol/l
24.1
23.8
1.47
374
1770
(3002030) Lymphocytes/100 leukocytes in Blood
1413
9805
1.60
31.30
8.8
6.9
%
32.3
32.8
0.67
1350
9251
(3024354) Oxygen [Partial pressure] in Venous blood
417
2115
1.91
28.99
8.2
7.8
kpa
5.1
5.0
0.49
410
2057
(3013650) Neutrophils [#/volume] in Blood by Automated count
1529
10942
1.57
28.57
12.0
8.8
e9/l
4.0
3.8
2.44
1325
9351
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
145
474
2.85
28.29
9.3
6.9
iu/ml
312.5
352.3
0.12
14
53
(3021589) Normoblasts [#/volume] in Blood
1303
9024
1.56
27.91
10.4
9.1
e9/l
0.0
0.0
0.86
1049
7140
(3007853) Bacteria identified in Skin by Aerobe culture
408
2082
1.89
27.77
2.1
1.6
—
—
—
0
0
(4010399)
210
832
2.37
27.74
1.7
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
595
3419
1.72
27.19
4.1
2.7
e6/l
8.1
7.8
0.17
519
2977
(3003458) Phosphate [Moles/volume] in Serum or Plasma
471
2537
1.80
26.92
12.4
8.1
mmol/l
1.3
1.2
1.57
449
2385
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1032
6850
1.56
26.20
13.4
8.1
mmol/l
1.2
1.2
1.01
975
6315
(3005322) IgE [Units/volume] in Serum or Plasma
334
1630
1.96
25.88
1.6
1.3
u/ml
422.1
369.9
0.26
309
1510
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
42
58
6.59
25.12
1.9
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1096
7425
1.54
25.08
13.2
7.8
mmol/l
1.2
1.2
0.06
976
6486
(3020779) Urea [Moles/volume] in Serum or Plasma
316
1543
1.95
24.39
14.5
10.2
mmol/l
6.9
6.1
1.65
305
1501
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
123
404
2.82
23.80
10.1
7.1
u/ml
673.2
1066.8
0.28
13
39
(3005719) IgG [Mass/volume] in Serum or Plasma
320
1588
1.92
23.51
4.3
3.1
g/l
9.8
10.0
0.42
308
1474
(3012095) Magnesium [Moles/volume] in Serum or Plasma
400
2139
1.79
23.17
11.0
7.2
mmol/l
0.8
0.8
0.63
381
2019
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
413
2237
1.77
22.90
5.8
3.9
ng/l
2033.5
1310.5
1.08
352
1789
(3026782) Osmolality of Urine
558
3283
1.66
22.89
3.8
2.7
mosm/kgh2o
577.0
590.1
0.50
490
2792
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
87
239
3.35
22.82
3.2
2.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
265
1250
2.00
22.53
2.1
1.8
g/l
1.2
1.2
0.03
253
1167
(3002582) Erythrocytes [#/volume] in Urine
799
5156
1.55
22.18
5.0
3.3
e6/l
36.1
71.4
1.26
641
3821
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
82
221
3.41
22.16
2.3
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
99
302
3.02
21.87
8.5
13.3
u/ml
0.3
0.4
1.76
65
165
(3000492) Spirometry study
295
1461
1.91
21.74
1.6
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1283
9179
1.47
21.49
7.1
5.2
mmol/l
6.3
6.1
1.40
1197
8322
(44806118)
92
273
3.10
21.31
2.1
1.9
—
—
—
0
0
(44790047)
92
273
3.10
21.31
2.1
1.9
—
—
—
0
0
(44790049)
92
273
3.10
21.31
2.1
1.9
—
—
—
0
0
(44790048)
92
273
3.10
21.31
2.1
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
66
158
3.82
21.22
2.0
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
69
171
3.69
21.13
2.5
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
85
242
3.23
21.08
2.2
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
167
688
2.26
20.12
1.5
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
864
5773
1.50
19.97
5.1
3.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
80
230
3.19
19.54
2.0
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
928
6314
1.48
19.52
5.7
3.8
e6/l
47.7
74.2
1.44
667
4105
(3023419) Bacteria identified in Sputum by Culture
42
77
4.96
18.87
5.9
4.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
726
4725
1.52
18.84
4.9
3.2
e6/l
0.3
0.3
0.45
561
3439
(3018677) aPTT in Platelet poor plasma by Coagulation assay
404
2292
1.68
18.74
4.5
4.3
s
30.9
30.3
1.01
389
2240
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
169
726
2.16
18.38
6.1
4.0
ng/l
237.6
180.5
0.74
157
632
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
83
256
2.97
18.03
3.1
3.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
206
961
2.00
18.01
1.2
1.1
u/ml
5.0
3.1
0.69
72
309
(3014111) Lactate [Moles/volume] in Serum or Plasma
265
1351
1.84
17.76
8.3
10.7
mmol/l
1.3
1.4
0.38
240
1255
(3015235) Bicarbonate [Moles/volume] in Capillary blood
116
434
2.46
17.38
7.8
5.2
mmol/l
23.7
23.7
0.03
109
392
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
224
1093
1.92
17.19
8.6
5.8
ng/l
79.3
63.4
1.47
210
1016
(36304419) Bacteria [Presence] in Urine
719
4748
1.49
17.12
4.9
3.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
90
303
2.73
16.69
3.3
3.2
e9/l
1.3
1.4
0.22
70
183
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
61
170
3.28
15.72
1.9
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
82
272
2.76
15.66
2.9
3.2
%
9.9
9.8
0.03
59
226
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
44
99
4.04
15.45
2.7
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
44
99
4.04
15.45
2.7
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
44
99
4.04
15.45
2.7
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
356
2054
1.64
15.31
3.7
2.4
g/l
2.5
2.5
0.31
337
1907
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
24
31
7.01
15.23
3.3
2.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
86
297
2.65
15.21
2.4
2.0
ug/l
2.4
3.2
0.29
77
255
(3027945) Reticulocytes/100 erythrocytes in Blood
318
1786
1.68
15.17
5.5
4.9
%
1.5
1.5
0.31
300
1641
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
103
389
2.43
15.16
1.9
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
673
4479
1.46
15.12
8.6
5.8
inr
1.1
1.1
0.17
227
1487
(40760888) Immunoglobulin light chains.free panel - Serum
45
105
3.90
15.06
9.8
2.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
219
1107
1.84
15.05
8.4
9.7
mmol/l
0.8
0.4
0.54
174
844
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
959
6830
1.40
14.74
8.6
5.7
umol/l
15.7
14.1
0.86
892
6262
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
53
141
3.43
14.70
2.0
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
493
3101
1.52
14.57
3.1
2.8
mg/l
1.4
1.3
0.18
340
2138
(3021901) Oxygen saturation in Capillary blood
81
279
2.66
14.41
5.7
3.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
60
176
3.11
14.26
1.4
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
384
2295
1.58
14.24
3.7
2.4
umol/l
13.8
14.2
0.37
368
2147
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
195
967
1.87
14.23
17.1
14.7
mg/l
1.2
1.1
2.25
189
937
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
217
1113
1.82
14.23
1.3
1.2
u/ml
3.1
2.5
0.25
149
618
(3020630) Protein [Mass/volume] in Serum or Plasma
152
693
2.03
14.17
5.7
2.8
g/l
65.2
66.0
0.53
141
645
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
190
939
1.88
14.01
2.3
1.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
183
895
1.90
13.94
6.2
7.2
%
94.1
93.6
0.12
177
863
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
363
2154
1.59
13.86
4.5
3.2
ng/l
1106.7
632.2
0.48
225
1245
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
329
1907
1.62
13.84
3.9
2.5
%
21.4
23.0
1.33
301
1716
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
135
595
2.09
13.79
10.7
13.1
mmol/l
24.3
24.0
0.42
126
570
(3027801) Oxygen [Partial pressure] in Arterial blood
215
1114
1.80
13.63
8.5
9.7
kpa
12.4
14.4
4.81
203
1068
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
215
1114
1.80
13.63
8.6
9.7
kpa
5.3
5.1
2.03
203
1065
(3007164) IgA [Mass/volume] in Serum or Plasma
843
5942
1.39
13.51
1.8
1.5
g/l
1.8
1.8
0.05
502
3395
(3042936) Bacteria identified in Isolate by Culture
320
1854
1.62
13.47
2.3
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
42
102
3.74
13.33
3.6
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
146
3.24
13.29
10.6
2.6
mg/l
37.6
27.4
0.78
42
118
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
146
3.24
13.29
10.6
2.6
mg/l
74.6
101.3
0.23
42
117
(3003888) Timothy IgE Ab [Units/volume] in Serum
196
1006
1.81
12.82
1.3
1.1
u/ml
7.7
7.6
0.02
152
680
(3016502) Oxygen saturation in Arterial blood
193
994
1.80
12.49
9.0
10.4
%
94.6
95.8
0.91
183
962
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
276
1571
1.64
12.45
4.7
3.7
g/l
0.2
0.2
0.18
266
1476
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
58
181
2.92
12.44
2.1
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
51
148
3.14
12.38
1.3
1.3
u/ml
1.2
0.7
0.35
18
34
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
88
340
2.37
12.38
1.7
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
163
801
1.88
12.25
4.7
5.4
%
160.3
160.9
0.03
157
776
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
148
709
1.93
12.01
2.2
1.7
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
14
12
10.54
11.98
2.2
1.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
168
844
1.84
11.79
5.2
6.1
g/l
3.1
3.0
0.45
163
816
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
51
4.80
11.79
2.2
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
187
977
1.77
11.54
1.3
1.1
u/ml
1.4
1.5
0.10
134
586
(3010375) cycloSPORINE [Mass/volume] in Blood
48
142
3.07
11.31
33.0
30.4
ug/l
150.8
142.0
0.21
41
130
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
61
208
2.67
11.14
1.3
1.3
u/ml
16.4
14.0
0.13
51
155
(3033658) Prothrombin time (PT) actual/Normal
588
4019
1.40
10.95
7.5
5.5
%
88.0
88.3
0.11
572
3933
(40767503) Oxygen content in Capillary blood by calculation
74
280
2.41
10.93
3.3
2.5
%
17.1
17.5
0.30
40
148
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
435
2819
1.46
10.86
4.0
3.0
e6/l
3.7
3.6
0.10
248
1502
(3036489) Thrombin time
169
873
1.79
10.84
4.8
5.3
s
22.4
22.2
0.18
155
792
(3022217) INR in Platelet poor plasma by Coagulation assay
186
991
1.74
10.73
21.1
15.6
inr
1.3
1.2
0.51
37
198
(1616796) Gas panel - Central venous blood
83
336
2.26
10.54
6.9
3.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
245
1412
1.61
10.50
7.1
5.4
u/l
240.3
263.6
1.31
234
1353
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
29
65
4.04
10.30
5.5
5.9
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
29
65
4.04
10.30
5.9
6.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
60
212
2.58
10.25
5.2
3.1
%
1.2
1.2
0.06
48
169
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
147
741
1.83
10.23
2.3
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
145
729
1.83
10.18
2.9
2.0
ug/l
6.1
5.9
0.03
121
624
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
434
2845
1.44
10.16
3.9
2.8
e6/l
0.8
1.0
1.58
243
1526
(3052851) Hemolysis interference index of Serum or Plasma
104
468
2.04
10.12
3.7
3.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
140
700
1.84
10.01
1.1
1.1
u/ml
11.3
5.8
1.30
83
357
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1098
8340
1.30
9.92
2.1
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
23
44
4.73
9.91
2.3
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
71
278
2.33
9.76
3.0
3.2
e6/l
552.2
533.7
0.11
57
201
(3023520) Reticulocytes [#/volume] in Blood
215
1222
1.63
9.74
4.1
4.1
e9/l
65.6
66.3
0.10
157
848
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
496
3356
1.40
9.69
2.8
2.2
u/l
350.8
258.0
0.49
475
3204
(3028192) IgG subclass 2 [Mass/volume] in Serum
61
224
2.48
9.65
1.4
1.3
g/l
2.5
2.5
0.08
48
181
(3000570) Elastase.pancreatic [Mass/mass] in Stool
84
359
2.14
9.38
1.5
1.3
ug/g
344.2
338.2
0.09
53
166
(21494814) CD8 cells/100 lymphocytes in Specimen
24
50
4.34
9.36
3.2
2.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
20
36
5.02
9.23
6.7
2.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
61
229
2.43
9.22
2.9
3.5
e6/l
346.3
317.2
0.21
43
143
(3024139) IgG subclass 3 [Mass/volume] in Serum
60
224
2.44
9.18
1.4
1.3
g/l
0.4
0.4
0.12
47
177
(3027135) IgG subclass 1 [Mass/volume] in Serum
60
224
2.44
9.18
1.4
1.3
g/l
6.7
6.2
0.31
46
180
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
32
84
3.45
9.15
2.3
1.6
—
—
—
0
0
(4062490)
60
225
2.43
9.10
1.4
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
35
98
3.24
9.07
4.3
5.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
264
1601
1.53
9.07
2.0
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
82
353
2.12
9.01
1.6
1.7
g/l
0.8
0.8
0.00
69
294
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
52
4.18
8.93
7.0
8.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
778
5705
1.31
8.90
9.6
5.6
g/l
37.1
37.5
1.12
741
5303
(3017181) Myelocytes/100 leukocytes in Blood
215
1250
1.59
8.89
6.5
4.4
%
0.5
0.6
0.40
78
327
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
54
195
2.52
8.87
8.8
4.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
69
279
2.25
8.84
3.1
3.2
e9/l
0.2
0.2
0.23
57
204
(3012501) Base excess in Blood by calculation
75
314
2.18
8.84
6.8
4.2
mmol/l
1.8
1.9
0.11
49
175
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
134
688
1.79
8.82
2.3
1.8
u/ml
93.2
101.8
0.26
14
78
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
22
45
4.42
8.78
2.4
1.7
—
—
—
0
0
(3010421) pH of Blood
83
363
2.09
8.76
6.6
4.0
ph
7.4
7.4
0.39
74
309
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
26
61
3.86
8.73
3.4
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
26
61
3.86
8.73
3.5
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
26
61
3.86
8.73
3.5
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
26
61
3.86
8.73
3.5
1.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
26
61
3.86
8.73
1.8
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
333
2140
1.45
8.61
1.7
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
13
16
7.33
8.55
3.2
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
603
4288
1.34
8.50
3.5
2.4
u/l
53.0
55.7
0.70
563
3911
(3042111) Morphology [Interpretation] in Bone marrow Narrative
44
147
2.72
8.44
2.4
2.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
628
4499
1.33
8.41
2.8
2.5
mg/l
2.8
2.7
0.63
555
3901
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
909
6848
1.29
8.38
3.8
2.6
nmol/l
68.5
68.3
0.09
849
6331
(3002385) Erythrocyte distribution width [Ratio]
2073
17274
1.30
8.37
19.8
12.7
%
13.3
13.2
3.00
2034
16854
(3012494) Peanut IgE Ab [Units/volume] in Serum
64
257
2.27
8.35
1.2
1.2
u/ml
115.5
17.3
0.44
51
199
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
69
286
2.20
8.35
1.1
1.1
iu/ml
9.5
6.0
—
9
54
(3036481) Cortisol [Moles/volume] in Serum or Plasma
300
1901
1.47
8.33
3.2
2.1
nmol/l
335.9
373.0
1.44
282
1758
(3025018) Bordetella pertussis Ab [Titer] in Serum
67
275
2.22
8.31
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
124
634
1.79
8.29
1.1
1.1
u/ml
14.7
9.6
0.67
72
349
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2270
19167
1.34
8.28
17.8
9.7
mg/l
22.3
22.1
0.09
1733
13683
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
123
628
1.80
8.27
1.9
1.7
g/l
1.1
1.1
0.38
118
608
(3042733) HLA Ab [Presence] in Serum
30
81
3.36
8.25
4.3
3.8
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
90
416
1.98
8.20
3.5
2.9
mu/l
17.8
23.7
1.39
85
383
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
291
1839
1.47
8.20
7.4
4.6
umol/l
6.0
7.1
1.29
251
1544
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
23
5.89
8.14
3.1
8.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
65
266
2.23
8.12
1.6
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
92
431
1.95
8.07
2.9
2.9
ug/l
323.3
265.7
0.38
84
388
(3004588) Protein electrophoresis panel - Serum or Plasma
91
425
1.96
8.06
6.7
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
88
407
1.97
8.01
2.0
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
546
3862
1.34
7.93
6.3
3.4
ph
7.4
7.4
0.38
114
696
(21494434) Karyotype in Bone marrow
38
122
2.83
7.86
1.4
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
24
5.64
7.81
1.9
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
30
84
3.23
7.81
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
197
1158
1.57
7.79
6.0
4.1
%
0.5
0.4
0.46
56
240
(3009445) Proteinase 3 Ab [Units/volume] in Serum
118
607
1.78
7.75
1.3
1.7
u/ml
2.4
10.1
—
6
34
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
55
214
2.34
7.74
2.9
3.0
e6/l
511.5
781.2
—
10
49
(3026008) Bacteria identified in Urine by Culture
671
4904
1.30
7.69
3.5
2.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1512
12189
1.25
7.64
5.1
3.6
mm/h
9.8
8.2
4.77
1404
11209
(3026493) Urate [Moles/volume] in Serum or Plasma
357
2377
1.40
7.56
5.6
3.1
umol/l
1125.0
4397.7
2.42
325
2119
(3002173) Hemoglobin [Mass/volume] in Arterial blood
158
888
1.64
7.53
8.6
9.8
g/l
122.7
123.6
0.20
152
862
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
231
2.24
7.33
6.1
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
231
2.24
7.33
6.1
1.9
g/l
7.5
7.4
0.06
42
185
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
231
2.24
7.33
6.1
1.9
g/l
3.4
3.6
0.67
40
177
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
115
599
1.76
7.26
3.3
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
41
144
2.58
7.18
4.9
3.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
216
2.27
7.16
5.5
1.9
g/l
9.2
9.9
0.50
45
191
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
95
470
1.85
7.11
1.1
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
76
349
1.98
7.10
1.6
1.3
u/ml
19.4
9.7
0.36
55
196
(3020874) Milk IgE Ab [Units/volume] in Serum
79
368
1.96
7.09
1.6
1.2
u/ml
10.1
3.2
1.00
61
216
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
155
882
1.61
7.05
1.8
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
340
2279
1.39
6.91
1.5
1.5
titre
684.2
527.4
0.83
48
406
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
705
5248
1.28
6.91
5.2
3.5
u/l
33.0
30.6
0.77
683
5001
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
108
561
1.76
6.90
10.8
13.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
132
725
1.67
6.90
7.1
5.6
g/l
0.3
0.4
0.43
92
431
(3023103) Potassium [Moles/volume] in Serum or Plasma
2053
17229
1.27
6.89
19.4
10.5
mmol/l
3.9
3.9
2.73
1984
16513
(3019550) Sodium [Moles/volume] in Serum or Plasma
2052
17222
1.27
6.86
19.1
10.5
mmol/l
139.5
139.5
0.46
1996
16577
(3021440) Promyelocytes/100 leukocytes in Blood
198
1200
1.52
6.85
6.8
4.5
%
0.0
0.1
0.61
72
304
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
171
1004
1.57
6.82
2.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
102
524
1.78
6.77
3.8
5.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
30
92
2.95
6.76
9.1
6.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
92
459
1.83
6.73
1.2
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
43
3.99
6.72
4.0
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
43
3.99
6.72
4.0
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
30
93
2.92
6.64
2.9
2.9
nmol/l
0.9
0.9
0.01
25
71
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
875
6709
1.25
6.64
1.5
1.6
u/ml
2.7
2.4
0.15
182
1468
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
150
860
1.60
6.63
1.3
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
48
3.77
6.55
2.8
3.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
33
109
2.74
6.53
2.7
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
150
864
1.59
6.51
1.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
541
3921
1.30
6.49
4.4
2.7
ng/l
59.7
96.8
0.25
300
1841
(3011897) Casein IgE Ab [Units/volume] in Serum
48
191
2.28
6.48
1.9
1.5
u/ml
23.0
11.0
0.31
14
46
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
0.4
1.5
1.99
13
46
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
1.3
1.1
0.07
13
48
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
2.7
2.4
0.08
16
51
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
1.0
2.5
1.26
13
50
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
4.9
4.4
0.08
14
48
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
1.1
1.1
0.02
16
50
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
1.2
1.2
0.03
14
52
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
1.6
1.7
0.05
15
50
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
1.5
1.0
0.39
15
45
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
22
57
3.49
6.48
1.9
1.8
mg/l
2.8
3.9
0.47
12
43
(3042631) Mycobacterium sp identified in Specimen
28
85
2.98
6.43
2.8
3.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1428
11563
1.23
6.43
5.6
3.8
e6/l
117.5
2126.5
2.34
35
169
(3034274) Bile acid [Moles/volume] in Serum --fasting
120
656
1.67
6.41
3.7
3.2
umol/l
10.1
8.0
0.37
103
529
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
16
33
4.38
6.35
2.3
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
189
1155
1.51
6.30
6.8
4.6
%
0.0
0.4
0.54
60
270
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
223
2.16
6.27
6.3
1.9
g/l
3.1
3.1
0.04
41
184
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1389
11243
1.22
6.18
9.4
5.8
u/l
97.5
89.1
4.70
1317
10485
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
163
971
1.54
6.13
2.1
1.6
u/ml
228.6
175.1
1.36
103
482
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
49
202
2.20
6.10
6.4
2.0
g/l
0.7
0.3
0.53
44
183
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
27
83
2.94
6.09
2.1
2.4
%
39.0
42.7
0.44
12
23
(4035726)
152
893
1.56
6.08
1.9
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
39
146
2.42
6.04
1.2
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
200
1257
1.46
5.82
2.1
1.9
u/l
6.3
6.8
0.34
144
934
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
62
286
1.97
5.78
1.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
101
543
1.70
5.77
2.9
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
231
1495
1.42
5.76
1.3
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
28
91
2.78
5.74
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
516
3774
1.28
5.71
3.5
2.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
19
49
3.50
5.65
4.1
1.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
17
41
3.74
5.55
2.9
2.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
101
550
1.68
5.52
1.2
1.1
u/ml
0.7
0.4
0.37
47
171
(3009508) Creatinine [Moles/volume] in Urine
603
4513
1.26
5.50
4.1
3.5
mmol/l
8.2
8.7
1.33
535
4038
(3020393) Adenovirus Ag [Presence] in Stool
41
165
2.25
5.44
2.4
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
64
306
1.90
5.41
2.7
2.7
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
20
56
3.23
5.27
1.7
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
631
4772
1.24
5.22
3.6
2.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
43
180
2.17
5.21
4.9
3.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
40
163
2.22
5.17
1.6
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
48
211
2.06
5.14
1.6
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
72
2.89
5.06
7.9
4.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
96
530
1.65
5.01
7.9
5.3
%
52.5
51.0
0.24
96
520
(3037467) Urinalysis macro (dipstick) panel - Urine
1453
11953
1.19
5.00
5.4
3.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
73
374
1.78
4.99
5.6
3.6
%
52.2
53.2
0.28
73
374
(3011397) Hemoglobin [Presence] in Urine by Test strip
550
4118
1.25
4.96
3.7
3.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
339
2390
1.31
4.94
4.6
4.3
mg/mmol
20.9
17.5
0.15
234
1714
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
426
3099
1.28
4.89
1.7
1.6
mmol/l
1.4
1.2
1.50
393
2756
(3048689) Calprotectin [Mass/mass] in Stool
473
3487
1.26
4.87
3.1
2.9
ug/g
104.7
117.4
0.39
378
2718
(3023183) Ammonium ion [Moles/volume] in Plasma
76
397
1.74
4.87
3.3
3.0
umol/l
33.4
33.0
0.07
69
352
(3006184) Hemoglobin [Mass/volume] in Capillary blood
75
391
1.74
4.84
3.1
2.2
g/l
131.5
134.2
0.52
54
323
(3003181) Sodium [Moles/volume] in Urine
50
229
1.98
4.82
3.3
3.0
mmol/l
69.4
78.4
0.74
44
205
(36660697) Celiac disease serology panel - Serum
358
2554
1.30
4.78
1.2
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
44
194
2.06
4.71
5.7
2.0
g/l
37.1
38.9
1.08
39
171
(3012516) Albumin [Mass/volume] in Urine
327
2313
1.31
4.66
4.1
3.6
mg/l
525.0
296.2
0.42
225
1658
(3023323) Follitropin [Units/volume] in Serum or Plasma
170
1085
1.44
4.62
2.2
1.9
iu/l
8.0
8.8
0.25
122
796
(40760892) CBC W Ordered Manual Differential panel - Blood
555
4194
1.24
4.58
7.3
4.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
210
1398
1.38
4.49
3.0
2.3
u/l
26.1
30.4
1.96
187
1160
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
61
308
1.80
4.41
1.2
1.4
u/ml
3.3
4.4
0.73
33
159
(3030905) Polymorphonuclear cells [#/volume] in Blood
69
365
1.72
4.27
4.4
3.5
e9/l
3.3
3.6
0.68
69
365
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2202
18923
1.22
4.27
4.3
3.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
24
85
2.55
4.25
1.4
1.3
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
52
253
1.86
4.24
1.0
1.0
kpa
7.6
7.2
0.65
45
216
(3004959) Base excess in Arterial cord blood by calculation
52
253
1.86
4.24
1.0
1.0
mmol/l
-1.8
-2.6
0.33
15
57
(3006598) pH of Arterial cord blood
52
253
1.86
4.24
1.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
44
203
1.96
4.20
9.5
3.7
mmol/l
7.8
6.5
0.77
38
158
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
10
20
4.51
4.12
4.2
1.5
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
51
250
1.85
4.08
1.0
1.0
kpa
3.3
3.2
0.11
44
213
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
68
367
1.68
3.94
2.0
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
191
1281
1.37
3.93
1.5
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
586
4519
1.21
3.92
3.4
2.6
mmol/l
2.4
2.4
0.80
529
4031
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
10
21
4.29
3.89
1.5
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
158
1032
1.40
3.82
1.5
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
21
74
2.56
3.78
1.7
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
21
74
2.56
3.78
1.8
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
21
74
2.56
3.78
1.8
1.3
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
108
2.26
3.72
1.1
1.1
%
84.5
94.1
0.97
16
53
(3003740) Influenza virus B Ag [Presence] in Specimen
87
509
1.55
3.67
1.3
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
87
509
1.55
3.67
1.3
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
310
2248
1.27
3.66
1.3
1.2
iu/ml
17.2
25.7
1.04
70
537
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
38
177
1.94
3.57
2.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
37
171
1.96
3.56
2.1
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
129
1602
0.71
3.53
1.1
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
146
955
1.40
3.52
6.3
3.3
mmol/l
1.2
1.2
0.52
133
813
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
58
310
1.70
3.52
1.8
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
85
500
1.54
3.52
2.0
2.2
g/l
1.4
1.3
0.72
73
430
(3024522) Salmonella sp identified in Specimen by Organism specific culture
37
172
1.95
3.50
2.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
37
172
1.95
3.50
2.1
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
54
284
1.72
3.47
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
25
100
2.26
3.47
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
37
173
1.94
3.45
2.1
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
67
2.56
3.43
2.6
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
67
2.56
3.43
2.6
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
162
1084
1.36
3.42
3.4
3.2
pmol/l
5.0
5.0
0.13
149
974
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
58
313
1.68
3.41
1.3
1.4
u/ml
2.0
4.6
1.73
22
125
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
37
174
1.92
3.40
2.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
26
108
2.18
3.31
2.2
1.3
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
20
74
2.44
3.29
1.2
1.1
u/ml
9.8
15.9
0.45
13
43
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
33
151
1.98
3.28
3.6
2.3
mmol/l
1.9
2.0
0.02
28
115
(3015076) Soybean IgE Ab [Units/volume] in Serum
55
296
1.68
3.28
1.2
1.1
u/ml
0.9
1.8
0.35
15
78
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
26
109
2.16
3.24
1.2
1.2
%
74.7
92.2
1.21
15
54
(3020891) Body temperature
71
409
1.58
3.24
7.8
5.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
9
17
4.77
3.20
2.3
3.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2232
19345
1.18
3.19
17.4
11.3
%
40.0
40.1
0.41
1865
16167
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
121
783
1.41
3.14
3.7
2.6
ml/min/173m2
77.9
81.8
0.32
55
268
(3024932) HLA-DR beta [Type]
24
99
2.19
3.12
1.2
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
25
105
2.15
3.12
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
48
253
1.72
3.10
2.0
1.9
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
18
4.51
3.06
4.7
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
14
5.15
3.06
1.6
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
30
138
1.96
2.97
1.7
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1697
14444
1.14
2.96
4.0
3.4
pmol/l
14.6
14.5
0.10
1562
12737
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
56
2.58
2.95
4.5
7.8
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
28
126
2.01
2.94
1.5
2.1
%
130.9
129.2
0.05
28
121
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
145
1.93
2.93
1.1
1.2
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
7
11
5.73
2.93
2.6
1.0
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
42
217
1.75
2.92
2.1
2.1
nmol/l
0.2
0.1
1.29
32
167
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
81
495
1.49
2.87
1.9
1.9
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
24
103
2.10
2.86
3.5
4.1
%
3.0
2.8
—
8
44
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
41
212
1.75
2.85
1.8
1.4
—
—
—
0
0
(4268621)
42
219
1.74
2.84
2.3
2.6
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
6
8
6.75
2.83
1.2
1.0
mg/l
55.8
31.0
—
6
8
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
85
527
1.46
2.81
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
65
382
1.54
2.77
5.0
12.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
285
2117
1.23
2.76
1.3
1.2
u/ml
12.9
8.0
0.42
92
728
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
30
142
1.91
2.76
1.6
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
26
117
2.01
2.75
4.9
3.1
%
56.1
51.1
0.36
11
76
(3023410) Appearance of Cerebral spinal fluid
54
305
1.60
2.73
2.5
3.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
96
1195
0.71
2.72
1.1
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
21
3.86
2.69
1.2
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
9
21
3.86
2.69
1.1
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
54
306
1.60
2.69
4.4
6.1
mmol/l
1.4
1.2
0.77
48
268
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
43
2.73
2.67
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2154
18692
1.16
2.66
11.2
7.7
u/l
27.2
25.7
1.44
2078
17956
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
12
38
2.85
2.66
2.3
2.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
161
1124
1.31
2.62
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
371
2846
1.20
2.61
1.6
1.4
nmol/l
19.9
19.0
0.49
333
2489
(3005011) Chlamydia sp Ab [Titer] in Serum
16
60
2.41
2.60
1.2
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
17
66
2.32
2.57
1.4
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
146
1.86
2.56
1.2
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
15
55
2.46
2.55
3.5
7.6
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
12
39
2.77
2.55
1.0
1.0
u/ml
0.4
4.7
0.52
12
23
(3007566) Smooth muscle Ab [Titer] in Serum
80
501
1.45
2.54
1.8
1.7
titre
53.8
62.7
—
8
63
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
81
509
1.44
2.53
2.4
2.7
e6/l
137.9
7987.9
0.53
67
395
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
81
509
1.44
2.53
2.4
2.7
e6/l
3.5
17.6
2.33
65
381
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
81
509
1.44
2.53
1.6
1.7
u/l
37.0
40.4
1.04
73
477
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
18
4.00
2.53
6.2
7.3
mmol/l
6.3
7.0
—
8
18
(3028308) Erythrocytes [#/volume] in Pleural fluid
16
61
2.37
2.52
1.3
1.5
e6/l
281666.7
43278.6
—
9
39
(3023199) Leukocytes [#/volume] in Pleural fluid
17
67
2.29
2.49
1.3
1.5
e6/l
3408.8
4470.1
0.17
12
46
(3021601) Nitrite [Presence] in Urine by Test strip
1035
8601
1.13
2.48
5.8
4.4
estimate
0.0
0.0
0.00
216
1701
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
20
85
2.12
2.47
1.2
1.1
u/ml
0.6
0.5
0.02
13
41
(3009261) Glucose [Presence] in Urine by Test strip
1041
8660
1.13
2.44
4.2
3.2
estimate
0.0
0.0
0.50
208
1666
(3019174) dRVVT (LA screen)
8
19
3.79
2.41
1.1
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
19
3.79
2.41
2.8
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
20
86
2.10
2.40
1.2
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1147
9606
1.12
2.39
3.4
2.8
ug/l
84.1
67.8
1.40
1078
8990
(3035350) Ketones [Presence] in Urine by Test strip
1034
8609
1.13
2.38
4.2
3.1
estimate
0.0
0.0
0.00
205
1628
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
52
2.43
2.33
3.1
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
52
2.43
2.33
3.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
52
2.43
2.33
1.3
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
602
4847
1.15
2.32
2.0
1.6
pmol/l
95.2
96.3
0.26
349
2593
(3016650) Hepatitis A virus Ab [Presence] in Serum
63
386
1.48
2.27
1.1
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
14
53
2.38
2.25
1.4
1.4
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
7
16
3.94
2.24
13.3
8.1
e6/l
64.3
96.8
—
7
9
(3036782) Glucose [Moles/volume] in Pleural fluid
15
59
2.29
2.23
1.2
1.3
mmol/l
5.7
6.2
0.27
15
54
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
305
2334
1.20
2.23
2.5
2.4
u/l
4317.4
7009.0
1.08
99
773
(3001964) Herpes simplex virus Ag [Presence] in Specimen
19
83
2.07
2.21
1.6
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
75
479
1.42
2.19
2.4
2.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
33
175
1.70
2.17
1.3
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
28
142
1.78
2.14
1.7
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
66
2.19
2.14
5.0
3.9
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
13
49
2.39
2.12
1.8
1.4
u/l
11.3
12.8
0.49
13
49
(3004451) EKG impression Narrative
8
22
3.28
2.11
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
28
143
1.77
2.10
1.1
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
52
312
1.51
2.09
1.2
1.2
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
19
85
2.02
2.09
1.2
1.5
%
86.7
94.3
0.58
19
80
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
18
79
2.06
2.08
1.2
1.2
%
63.6
70.0
—
5
18
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
18
79
2.06
2.08
1.2
1.1
%
83.6
86.7
—
5
18
(4015189)
6
13
4.16
2.07
4.7
2.5
—
—
—
0
0
(4306422)
47
277
1.53
2.06
1.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
26
131
1.79
2.04
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
22
105
1.89
2.04
2.7
2.7
u/ml
1074.4
849.3
0.47
22
105
(3017704) Immunofixation for Urine
9
28
2.90
2.03
4.9
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
27
138
1.77
2.03
1.1
1.2
nmol/l
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
18
3.50
2.02
1.9
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
212
1584
1.22
2.00
5.1
3.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
46
272
1.53
1.99
3.6
3.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
53
325
1.48
1.94
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
40
2.48
1.93
2.7
2.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2096
18280
1.12
1.92
20.6
12.2
g/l
334.1
334.6
1.53
2073
18063
(3024731) MCV [Entitic volume]
2505
22109
1.18
1.92
23.1
14.0
fl
87.8
88.0
1.33
2469
21701
(3026389) Candida sp identified in Specimen by Organism specific culture
47
282
1.51
1.92
1.2
1.2
—
—
—
0
0
(3013512) EKG study
381
3013
1.16
1.89
4.1
2.7
—
—
—
0
0
(3044889) 12 lead EKG panel
1042
8769
1.11
1.89
3.1
2.6
—
—
—
0
0
(4198724)
50
306
1.48
1.86
1.9
2.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
30
163
1.66
1.85
2.0
1.9
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
6
15
3.60
1.84
1.5
2.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2502
22092
1.17
1.84
23.2
14.1
e9/l
263.5
261.4
0.83
2426
21202
(3026361) Erythrocytes [#/volume] in Blood
2505
22121
1.17
1.83
23.1
14.0
e12/l
4.6
4.6
0.57
2416
21171
(3035941) MCH [Entitic mass]
2504
22113
1.17
1.82
23.1
14.0
pg
29.4
29.5
2.41
2468
21705
(3016273) Islet cell 512 Ab [Units/volume] in Serum
16
71
2.03
1.82
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
44
264
1.51
1.81
2.3
2.9
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
25
130
1.74
1.80
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
38
221
1.55
1.79
3.9
2.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
36
2.50
1.79
2.7
2.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2506
22137
1.17
1.79
23.2
14.1
e9/l
7.2
6.8
6.51
2415
21202
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
29
158
1.66
1.78
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
182
1358
1.22
1.77
1.5
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
11
4.09
1.77
2.4
1.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2506
22140
1.17
1.77
23.4
14.2
g/l
134.7
135.6
2.46
2470
21734
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
60
385
1.41
1.76
1.1
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
230
1757
1.19
1.76
1.3
1.2
titre
544.0
126.8
—
5
65
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
22
111
1.79
1.75
1.2
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
21
3.00
1.75
1.9
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1900
16515
1.11
1.75
4.5
4.0
mu/l
1.9
2.0
0.49
1801
15360
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
304
1.46
1.73
1.4
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
62
402
1.40
1.72
1.3
1.2
u/ml
4.7
22.6
—
10
47
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
21
105
1.80
1.72
1.2
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
92
638
1.31
1.67
1.3
1.3
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
12
3.75
1.65
1.6
2.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
192
0.47
1.65
6.0
2.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
17
3.18
1.64
3.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
566
4640
1.12
1.64
4.5
3.3
estimate
0.0
0.0
0.80
208
1642
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
298
2341
1.16
1.64
1.4
1.5
pmol/l
480.1
13984338.3
1.54
246
1988
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
21
107
1.77
1.63
1.2
1.1
u/ml
4.1
1.6
0.30
13
51
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
155
1.63
1.63
1.1
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
28
2.57
1.63
1.5
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
44
271
1.47
1.62
1.2
1.2
%
108.5
110.5
0.11
39
249
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
66
438
1.36
1.62
1.2
1.2
u/ml
41.5
33.0
—
5
20
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
577
4740
1.12
1.61
1.8
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1297
11097
1.09
1.61
4.6
3.1
u/l
36.5
30.5
2.82
1237
10501
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
20
101
1.79
1.60
1.3
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
23
2.74
1.59
1.1
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
33
192
1.55
1.58
4.9
4.6
ug/l
2.0
1.9
0.09
33
185
(3019225) pH of Specimen
146
1082
1.22
1.55
6.3
3.3
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
13
3.46
1.55
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
85
593
1.30
1.51
1.3
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
24
131
1.65
1.49
1.6
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
19
2.84
1.48
1.5
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
60
399
1.36
1.47
1.3
1.2
u/ml
1.7
8.6
—
5
41
(3002256) Pathology report gross observation
189
1445
1.19
1.47
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
21
111
1.71
1.47
3.6
2.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
11
46
2.15
1.47
1.0
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
14
3.21
1.45
1.4
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
492
4842
0.90
1.45
2.1
2.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
192
1474
1.18
1.43
1.7
1.6
mu/l
346.6
327.5
0.45
177
1328
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
35
2.32
1.42
1.3
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
871
7352
1.09
1.42
5.0
4.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
60
402
1.35
1.42
2.3
2.2
nmol/l
0.9
0.6
0.98
52
340
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
20
2.70
1.40
1.2
1.3
%
6.2
1.4
—
6
14
(3016330) Potassium [Moles/time] in 24 hour Urine
6
20
2.70
1.40
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
83
586
1.28
1.37
1.3
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
54
2.00
1.35
1.8
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
12
54
2.00
1.35
1.5
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
15
74
1.83
1.32
1.1
1.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
29
172
1.52
1.32
2.6
3.7
u/ml
45.2
151.4
—
7
53
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
20
108
1.67
1.32
1.6
1.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
56
377
1.34
1.30
1.3
1.1
iu/ml
184.2
170.1
0.04
13
125
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
81
575
1.27
1.29
1.3
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
11
49
2.02
1.28
1.5
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
13
62
1.89
1.26
1.0
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
148
1125
1.19
1.26
2.1
2.3
au/ml
24.8
17.1
—
9
82
(3022621) pH of Urine by Test strip
133
1001
1.20
1.26
2.5
2.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
140
1059
1.20
1.26
2.1
2.1
e9/l
4.0
4.2
0.27
123
867
(3011648) Oxygen content in Venous blood
33
204
1.46
1.25
5.6
19.7
%
12.0
11.5
0.37
33
204
(3008037) Lactate [Moles/volume] in Venous blood
35
219
1.44
1.25
5.0
3.5
mmol/l
1.4
1.5
0.57
35
213
(3041806) Other cells [#/volume] in Blood by Manual count
33
422
0.70
1.24
1.3
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
15
76
1.78
1.23
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
76
1.78
1.23
1.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
23
132
1.57
1.22
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
30
183
1.48
1.22
1.1
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
17
2.65
1.21
1.4
1.2
umol/24h
230.0
283.7
—
5
17
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
24
140
1.55
1.19
1.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
8
34
2.12
1.18
1.9
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
82
592
1.25
1.17
1.6
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
223
1765
1.15
1.17
1.3
1.3
iu/ml
94.3
133.4
1.04
74
595
(40768804) Tissue Pathology biopsy report
582
4867
1.09
1.16
2.0
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
58
1.86
1.14
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
127
963
1.19
1.14
1.7
1.7
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
19
106
1.62
1.13
1.2
1.1
u/ml
1.1
6.2
0.66
11
50
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
23
135
1.54
1.12
1.6
3.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
23
135
1.54
1.12
1.6
3.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
85
620
1.24
1.12
3.2
2.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
8
36
2.00
1.11
1.1
1.3
u/l
13.5
11.8
—
8
36
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1349
11683
1.07
1.11
4.6
3.6
mmol/mol
37.5
36.7
1.79
1265
10909
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
117
884
1.20
1.10
1.4
1.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
18
100
1.62
1.10
5.8
3.5
umol/l
148.7
120.6
—
7
33
(3051387) C reactive protein [Mass/volume] in Capillary blood
57
397
1.30
1.09
4.1
2.9
mg/l
23.3
28.1
0.52
42
242
(3035933) Granulocytes/100 leukocytes in Blood
32
203
1.42
1.09
1.4
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
106
1138
0.83
1.09
1.8
1.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
46
1.96
1.08
1.8
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
183
1877
0.87
1.08
1.1
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
11
53
1.87
1.06
2.4
1.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
19
109
1.57
1.03
2.4
2.5
ug/l
28.0
239.3
0.49
19
99
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
20
2.25
1.01
1.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
5
20
2.25
1.01
4.2
3.4
mmol/l
4.1
4.5
—
5
20
(40758292) HTLV I+II Ab panel - Serum
11
54
1.83
1.01
1.6
1.2
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
18
103
1.57
0.99
1.4
1.6
iu/ml
—
411250.0
—
0
9
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
18
103
1.57
0.99
1.0
1.1
u/l
86.6
197.7
1.31
11
74
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
103
1096
0.84
0.98
1.6
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
29
185
1.41
0.98
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
134
1039
1.17
0.96
1.1
1.2
au/ml
14.7
33.7
—
6
33
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
9
45
1.80
0.96
1.2
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
91
682
1.21
0.96
1.5
1.6
iu/ml
0.0
0.2
1.39
16
157
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
488
4703
0.92
0.95
2.5
2.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
180
1428
1.14
0.95
2.4
2.1
nmol/l
10.0
10.7
0.50
154
1241
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
416
4036
0.91
0.95
2.3
2.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
13
69
1.70
0.94
4.2
1.3
u/l
210.7
188.0
0.53
13
69
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
76
1.66
0.94
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
33
1.91
0.94
1.7
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
9
46
1.76
0.94
1.2
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
131
0.55
0.93
1.4
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
105
1.54
0.93
2.9
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
152
1196
1.15
0.91
3.7
2.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
252
2049
1.12
0.90
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
70
1.67
0.90
1.4
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
121
1.49
0.89
1.1
1.1
ratio
1.1
1.1
—
7
49
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
78
1.62
0.87
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
229
1858
1.12
0.86
1.8
1.6
nmol/l
1113.0
1129.8
0.10
187
1398
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
40
1.80
0.85
2.4
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
71
527
1.22
0.85
2.7
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
743
7014
0.94
0.85
2.7
2.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
24
153
1.41
0.84
1.1
1.1
mg/l
300.3
288.9
0.31
24
140
(3051593) INR in Capillary blood by Coagulation assay
6
28
1.93
0.83
1.3
14.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
6
28
1.93
0.83
7.7
5.2
ug/min
50.7
37.7
—
6
18
(3035880) pH of Pleural fluid
6
28
1.93
0.83
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
14
79
1.60
0.83
1.2
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
51
1.77
0.83
4.9
2.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
41
1.76
0.83
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
132
1037
1.15
0.83
4.3
3.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
255
1.31
0.81
6.6
3.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
80
1.58
0.80
1.3
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
8
43
1.67
0.79
1.0
1.2
u/l
32.1
10.5
—
8
29
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
25
163
1.38
0.78
1.4
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
126
1290
0.87
0.78
3.4
2.9
%
33.8
33.0
0.36
98
928
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
30
1.80
0.77
1.8
2.3
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
25
0.00
0.77
0.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
174
1403
1.12
0.75
7.2
4.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
239
1964
1.10
0.74
2.8
2.4
mmol/l
2.4
2.4
0.28
204
1703
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
25
165
1.37
0.74
1.4
1.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
14
82
1.54
0.73
1.7
1.6
nmol/l
17.9
19.0
—
8
24
(44813793)
38
268
1.28
0.73
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
50
1.62
0.72
1.2
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
26
310
0.75
0.72
1.5
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
36
1.75
0.71
1.6
1.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
50
366
1.23
0.71
1.1
1.2
u/ml
27.8
35.7
—
5
19
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
10
54
1.67
0.71
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
25
167
1.35
0.69
1.5
1.4
umol/l
10.7
10.4
0.09
25
160
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
24
1.87
0.69
1.2
1.3
%
57.8
62.7
—
5
15
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
31
216
1.29
0.66
1.4
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
73
560
1.18
0.66
1.2
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
129
1299
0.89
0.65
1.3
1.3
miu/ml
270.2
233.8
0.47
58
649
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
802
7493
0.95
0.65
2.8
2.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
84
870
0.86
0.64
2.8
2.8
ug/l
0.7
0.8
0.01
56
520
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
40
1.57
0.64
1.9
2.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
40
1.57
0.64
1.9
2.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
70
537
1.18
0.63
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
88
907
0.87
0.63
1.7
2.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
65
497
1.18
0.62
1.2
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
9
126
0.64
0.60
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
205
1693
1.10
0.60
2.1
2.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
46
1.57
0.60
1.3
1.3
ug/l
10.1
10.3
—
8
46
(3037556) Urate [Mass/volume] in Serum or Plasma
0
20
0.00
0.59
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
141
1144
1.11
0.59
1.6
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
31
221
1.26
0.58
1.5
1.4
promille
1.5
1.2
0.64
26
162
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
25
173
1.30
0.58
1.7
1.5
pmol/l
319.8
446.0
0.78
19
149
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
15
95
1.42
0.57
3.3
2.1
umol/l
14.0
16.5
0.43
15
95
(40759836) Histone Ab [Presence] in Serum by Immunoblot
27
189
1.29
0.57
1.1
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
28
197
1.28
0.57
1.4
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
126
1.36
0.57
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
421
3587
1.07
0.57
1.8
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
49
1.47
0.56
1.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
58
1.55
0.56
1.2
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
81
0.55
0.56
1.6
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
27
190
1.28
0.56
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
27
190
1.28
0.56
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
27
190
1.28
0.56
1.1
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
18
119
1.36
0.55
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
363
3081
1.07
0.55
1.7
1.6
%
1.4
1.4
0.88
325
2797
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
21
143
1.32
0.54
2.0
1.8
mg/l
11.0
27.0
—
5
38
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
54
1.50
0.54
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
116
1159
0.90
0.54
1.6
1.9
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
199
1.27
0.54
2.9
2.6
ug/min
93.2
104.3
0.06
19
127
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
27
191
1.27
0.54
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
27
191
1.27
0.54
1.1
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
55
421
1.18
0.54
2.4
1.8
iu/l
5.1
4.7
0.10
15
155
(3028707) Methadone [Presence] in Urine by Screen method
157
1290
1.10
0.53
2.1
2.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
33
240
1.24
0.53
2.2
2.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
59
1.53
0.53
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
244
2046
1.08
0.52
1.6
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
26
184
1.27
0.52
1.4
2.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
36
1.50
0.51
2.0
2.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
98
1.38
0.50
2.1
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
15
98
1.38
0.50
2.7
2.1
u/field
2.7
1.8
—
9
56
(40761511) CBC panel - Blood by Automated count
2226
19804
1.05
0.50
14.0
8.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
116
1152
0.90
0.50
1.6
1.6
—
—
—
0
0
(3049233) Organic acids panel - Urine
10
60
1.50
0.49
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
34
251
1.22
0.49
1.1
1.2
—
—
—
0
0
(3032641) Amino acids panel - Urine
7
41
1.54
0.48
1.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
31
227
1.23
0.48
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
91
1.39
0.48
1.4
1.2
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
15
99
1.36
0.48
1.7
2.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
43
1.46
0.47
1.1
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
105
0.68
0.46
1.3
1.1
—
—
—
0
0
(4024509)
8
105
0.68
0.46
1.1
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
172
1.26
0.45
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
45
1.40
0.45
1.7
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
549
5126
0.95
0.45
1.9
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
500
4318
1.05
0.44
3.7
3.0
kg/l
1.0
1.0
0.49
110
656
(3002621) Streptococcal DNAse B [Units/volume] in Serum
14
93
1.36
0.43
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
81
652
1.12
0.43
1.9
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
28
1.61
0.43
2.6
3.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
164
1587
0.92
0.42
4.3
4.3
ug/l
2.3
2.4
0.10
148
1403
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
84
0.64
0.42
1.0
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
16
0.00
0.40
0.0
1.1
—
28.6
—
0
10
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
200
1.22
0.40
1.2
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
28
209
1.21
0.39
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
56
444
1.14
0.38
1.5
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
32
1.41
0.38
1.2
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
32
1.41
0.38
3.2
1.9
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
9
60
1.35
0.38
1.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
61
1.33
0.37
1.1
1.2
nmol/l
128.4
130.8
—
9
61
(3000012) Reticulocyte production index
9
61
1.33
0.37
1.3
2.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
80
1.35
0.37
1.5
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
33
1.36
0.37
1.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
63
1.29
0.36
5.8
7.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
34
356
0.86
0.36
1.7
1.7
mmol/l
7.0
7.1
0.07
26
210
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
30
228
1.18
0.35
1.4
1.5
mmol/l
13.0
10.5
—
7
37
(3028679) Herpes simplex virus Ab [Presence] in Serum
23
170
1.22
0.35
1.4
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
222
2107
0.94
0.35
2.0
2.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
121
1.26
0.35
1.8
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
141
0.76
0.35
1.2
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
113
0.72
0.35
1.7
1.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
39
1.38
0.35
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
248
2344
0.95
0.34
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
561
4896
1.04
0.33
4.0
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
29
222
1.18
0.32
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
625
5471
1.03
0.31
1.9
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
873
7685
1.03
0.31
2.3
2.2
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
24
182
1.19
0.30
2.8
4.6
au/ml
205.1
110.1
—
5
23
(3017509) Phencyclidine [Presence] in Urine
7
50
1.26
0.29
1.7
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
37
292
1.14
0.29
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
31
242
1.15
0.28
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
108
907
1.07
0.28
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
80
777
0.92
0.27
1.4
1.5
mg/l
3.9
3.7
0.09
53
506
(3035947) Staphylolysin Ab [Units/volume] in Serum
12
85
1.27
0.26
1.0
1.1
—
4.5
—
0
11
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
128
1221
0.94
0.26
4.3
3.9
%
20.8
21.7
0.27
54
510
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
10
115
0.78
0.26
6.0
4.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
10
115
0.78
0.26
3.0
2.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
65
636
0.92
0.26
1.3
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
15
110
1.23
0.26
4.3
3.4
u/ml
11983.8
363.1
—
9
101
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
325
3021
0.96
0.25
1.5
1.5
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
67
1.21
0.25
6.2
7.0
—
—
—
0
0
(4146454)
9
69
1.17
0.24
3.4
3.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
104
994
0.94
0.24
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
48
392
1.10
0.24
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1528
13878
0.98
0.23
3.2
2.8
mmol/l
5.6
5.5
1.45
1404
12711
(3000475) Leukocytes [#/volume] in Synovial fluid
27
213
1.14
0.23
1.7
1.7
e6/l
16587.7
16503.0
0.00
20
159
(4133840)
5
35
1.28
0.23
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
163
1400
1.05
0.22
1.9
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
305
2829
0.97
0.22
1.8
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
44
360
1.10
0.22
2.4
1.9
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.21
0.0
1.6
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.21
0.0
1.1
—
1.4
—
0
9
(3036180) Methadone [Presence] in Urine
0
9
0.00
0.21
0.0
2.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
9
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038702) Sodium [Moles/volume] in Capillary blood
0
12
0.00
0.21
0.0
3.1
—
139.8
—
0
12
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017950) Salicylates [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
2085.6
—
0
5
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
722
6603
0.98
0.20
1.7
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
742
6560
1.02
0.20
4.3
3.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
13
0.00
0.20
0.0
6.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
44
1.23
0.20
2.7
3.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
97
1.21
0.20
1.1
1.1
—
—
—
0
0
(4027681)
22
174
1.14
0.19
1.2
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
53
1.19
0.18
3.1
2.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
74
627
1.06
0.17
2.6
3.7
ug/l
3.5
25.8
0.96
49
473
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
55
1.14
0.17
1.0
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
28
227
1.11
0.17
3.4
2.0
mosm/kgh2o
293.5
291.3
0.26
19
173
(3016031) Almond IgE Ab [Units/volume] in Serum
11
82
1.21
0.17
1.1
1.1
u/ml
1.8
1.6
0.10
11
65
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
70
593
1.06
0.17
1.6
1.5
nmol/l
38.3
38.2
0.01
70
582
(3044941) Cell count panel - Synovial fluid
18
142
1.14
0.16
1.3
1.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
9
70
1.16
0.15
1.0
1.0
u/ml
37.0
49.0
—
9
70
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
71
1.14
0.15
1.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
75
1.20
0.14
1.2
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
11
84
1.18
0.13
2.6
3.1
u/ml
19.5
25.6
0.27
11
84
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
83
780
0.96
0.13
1.0
1.1
u/ml
5.6
6.5
—
8
89
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
10
105
0.86
0.12
1.1
1.0
u/l
0.9
1.0
—
5
44
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
50
475
0.95
0.12
1.5
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
333
3048
0.98
0.12
1.7
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
84
786
0.96
0.12
1.7
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1551
14015
0.99
0.10
13.5
7.8
ml/min/173m2
103.3
102.8
0.22
1178
10187
(3005033) Fetal Nuchal fold Thickness US
84
783
0.96
0.10
1.6
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
262
2399
0.98
0.10
1.8
2.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
103
0.87
0.10
1.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
118
1031
1.03
0.10
1.6
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
42
1.07
0.09
1.2
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
57
491
1.04
0.09
1.6
1.6
nmol/l
0.2
0.3
0.76
47
400
(3050129) First trimester maternal screen panel - Serum or Plasma
167
1534
0.98
0.09
1.5
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
48
1.12
0.09
1.5
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
66
616
0.96
0.09
1.7
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
16
131
1.10
0.08
1.1
1.1
miu/ml
1910.8
1444.2
0.81
16
131
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
54
0.83
0.08
1.6
2.4
nmol/l
0.6
1.3
—
5
45
(3045716) Anion gap in Serum or Plasma
5
57
0.79
0.08
5.0
1.4
mmol/l
7.6
10.4
—
5
50
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
57
1.10
0.08
6.0
6.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
118
1036
1.03
0.07
1.6
1.4
—
—
—
0
0
(4281824)
6
65
0.83
0.07
1.3
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
118
1037
1.02
0.07
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
118
1037
1.02
0.07
1.6
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
73
0.86
0.07
1.6
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
7
75
0.84
0.07
1.6
1.6
%
37.4
40.5
—
7
57
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1525
13663
1.01
0.06
3.5
3.0
mmol/l
2.6
2.6
1.33
1424
12696
(3043238) Trisomy 21 risk [Likelihood] in Fetus
87
802
0.97
0.06
1.6
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
9
91
0.89
0.06
1.3
1.1
nmol/l
362.9
398.2
—
9
85
(3028300) Cannabinoids [Presence] in Urine
339
3079
0.99
0.06
1.7
1.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
48
447
0.96
0.06
1.0
1.1
u/ml
4.6
3.2
0.21
15
155
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
118
0.91
0.06
2.1
1.5
—
—
—
0
0
(4034850)
42
391
0.97
0.05
7.7
7.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
22
187
1.06
0.05
1.6
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
58
536
0.97
0.05
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
23
196
1.06
0.05
1.4
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
42
365
1.04
0.05
1.9
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1439
12905
1.01
0.04
3.2
2.7
mmol/l
1.2
1.1
3.25
1365
12073
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1523
13669
1.00
0.03
3.5
2.9
mmol/l
4.3
4.4
3.13
1447
12826
(3027008) Opiates [Presence] in Urine
340
3074
0.99
0.03
1.7
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
22
190
1.04
0.02
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1498
13447
1.00
0.02
3.4
2.9
mmol/l
1.4
1.4
7.54
1405
12566
(3027944) Amphetamines [Presence] in Urine
334
3018
0.99
0.02
1.7
1.9
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
17
146
1.05
0.02
2.5
3.5
umol/l
105.0
197.9
—
9
82
(3045683) HLA typing for celiac disease panel - Blood or Tissue
21
183
1.03
0.01
1.0
1.0
—
—
—
0
0
(4094501)
17
152
1.01
0.00
1.1
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
118
0.99
0.00
1.2
1.1
iu/ml
221.8
242.6
0.16
13
118
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
16
140
1.03
0.00
1.1
1.2
—
28.4
—
0
5
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
11
98
1.01
0.00
1.6
2.6
nmol/l
153.9
157.4
0.03
11
88
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
113
1.03
0.00
1.1
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
15
130
1.04
0.00
1.3
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
10
88
1.02
0.00
3.1
1.3
—
69.5
—
0
10
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
72
645
1.00
0.00
1.3
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
88
794
1.00
0.00
1.5
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
11
100
0.99
0.00
2.5
3.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
19
170
1.00
0.00
1.6
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
207
1.00
0.00
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
230
2064
1.00
0.00
1.3
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
65
0.97
0.00
1.4
2.5
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
5
49
0.92
0.00
1.4
1.4
nmol/l
73.4
103.6
—
5
36
(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
8
76
0.95
0.00
1.4
2.7
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
76
0.95
0.00
1.5
1.4
g/l
1.2
0.9
—
8
76
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
9
82
0.99
0.00
1.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
73
0.99
0.00
1.4
2.7
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.8
—
0.1
—
0
8
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
91.2
—
0
6
(3017894) Mustard IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
53.2
—
0
5
(3020399) Glucose [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3017497) Pine Nut IgE Ab [Units/volume] in Serum
0
7
0.00
-0.00
0.0
1.0
—
0.1
—
0
7
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
-0.00
0.0
1.3
—
20.4
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint J10_BRONCHIOLITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_BRONCHIOLITIS | 2.308 [1.87, 2.84] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.057 |
During the follow-up period (1.1.1998 — 31.12.2019), 1374 out of 42105 females with J10_BRONCHIOLITIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_BRONCHIOLITIS | 2.394 [1.83, 3.13] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 1410 out of 66255 males with J10_BRONCHIOLITIS died.
Mortality risk
Mortality risk for people of age
years, who have J10_BRONCHIOLITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.211% | 0.33% |
| 5 | 1.194% | 2.613% |
| 10 | 3.184% | 6.478% |
| 15 | 5.797% | 12.763% |
| 20 | 9.852% | 21.322% |
Relationships between endpoints
↥Index endpoint: J10_BRONCHIOLITIS – Acute bronchiolitis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data